Polypoid tumors of the major duodenal papilla: preoperative staging with intraductal US, EUS, and CT — a prospective, histopathologically controlled study

Menzel, J.; Hoepffner, N.; Sulkowski, U.; Reimer, Peter; Heinecke, A.; Poremba, Christopher; Domschke, Wolfram

doi:10.1016/s0016-5107(99)70012-x

Cited by 144 publications

(96 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Sensitivity and specificity rates for IDUS and EUS were 100% versus 62.5% and 75% versus 50%, respectively. Overall accuracy rate in tumour diagnosis for IDUS was reported significantly superior to EUS (89% vs 56%) [35]. However in our hands as well as in other studies [25,[27][28][29]31,33] overall diagnostic accuracy for tumour detection was higher reaching levels as high as 84%.…”

Section: Figurecontrasting

confidence: 50%

See 1 more Smart Citation

Ampulla of Vater Cancer with Cholangitis and Pancreatitis

Kim¹

2016

Clin Ultrasound

View full text Add to dashboard Cite

Section: Figurecontrasting

confidence: 50%

“…IDUS appears to be the most effective imaging method in visualizing and staging tumors of the papilla but this remains to be confirmed by other studies. Combining ERCP with a catheter probe sonography offers a new diagnostic modality that has some potential advantages for local staging of small tumours of the papilla [35][36][37].…”

Section: Figurementioning

confidence: 99%

Ampulla of Vater Cancer with Cholangitis and Pancreatitis

Kim¹

2016

Clin Ultrasound

View full text Add to dashboard Cite

“…We believe, as other authors that if the clinical suspicion for invasive carcinoma is low (e.g., absence of jaundice, endoscopic features of noncancerous lesion), and the lesion appears amenable to endoscopic resection, then EUS may not impact the endoscopist's decision to stage the lesion via ampullectomy. Few studies have been reported comparing efficacy of EUS and intraductal ultrasound (IDUS) for ampullary neoplasms [54,60,64] . IDUS was superior to EUS in terms of tumor visualization and staging (staging accuracy: 78%-93%).…”

Section: Eusmentioning

confidence: 99%

Endoscopic management of adenomatous ampullary lesions

Espinel¹

2015

WJM

View full text Add to dashboard Cite

Lesions of the ampulla of Vater represent an uncommon group of gastrointestinal malignancies. The majority of lesions of the ampulla of Vater are either adenomas or adenocarcinomas. Ampullary lesions are often incidental findings. Accurate preoperative diagnosis and staging of ampullary tumors is imperative for predicting prognosis and determining the most appropriate therapeutic approach. Endoscopic ampullectomy is a safe and efficacious therapeutic procedure that can obviate the need for potentially major surgical intervention. This review will provide the framework for the diagnosis and management of ampullary lesions from the perspective of the practicing gastroenterologist. Strategies for safe and successful endoscopic ampullectomy with a focus on accurate preoperative diagnosis and staging, resection technique, and management of complications are presented. Core tip: Adenomatous ampullary lesions are rare. Endoscopic retrograde cholangiopancreatography and endoscopic ultrasound (EUS) have changed the management of patients with these lesions. Endoscopic ampullectomy is a technique that has revolutionized the treatment of these lesions avoiding potential complications of surgery. We herein discuss the epidemiology, the role of EUS in the local staging and the role of endoscopy in the treatment of the adenomatous ampullary neoplasms.Espinel J, Pinedo E, Ojeda V, Guerra del Rio M. Endoscopic management of adenomatous ampullary lesions. World J REVIEW

show abstract

“…Intraductal ultrasound (IDUS) is yet another method of visualizing ampullary tumors by use of a high-frequency ultrasound probe (20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30) inserted into the bile duct during ERCP. Various studies have shown superior T staging for IDUS compared to EUS [56,58,59], with overall accuracy for tumor staging ranging between 78-88% for IDUS. Limitations of IDUS include the necessity of ERCP for staging and cannulation of the bile duct (which may be difficult with larger tumors), cost of the probe, potential damage to the probe by the duodenoscope elevator, and its limited availability.…”

Section: Staging Of Ampullary Tumorsmentioning

confidence: 99%